The cost-burden of paediatric pneumococcal disease in the UK and the potential cost-effectiveness of prevention using 7-valent pneumococcal conjugate vaccine
- 1 June 2003
- Vol. 21 (19-20) , 2564-2572
- https://doi.org/10.1016/s0264-410x(03)00031-8
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumoniaThe Pediatric Infectious Disease Journal, 2002
- Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine?Archives of Disease in Childhood, 2002
- New rapid antigen test for diagnosis of pneumococcal meningitisThe Lancet, 2001
- Antibody Concentration and Clinical Protection After Hib Conjugate Vaccination in the United KingdomPublished by American Medical Association (AMA) ,2000
- Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996–1998Acta Paediatrica, 2000
- Projected Cost-effectiveness of Pneumococcal Conjugate Vaccination of Healthy Infants and Young ChildrenJAMA, 2000
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States InfantsPediatrics, 1998
- Community-acquired pneumonia: the annual cost to the National Health Service in the UKEuropean Respiratory Journal, 1997
- Outcomes of bacterial meningitis in childrenThe Pediatric Infectious Disease Journal, 1993